Global Insulin Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

Global Insulin Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030


Summary

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

According to APO Research, The global Insulin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Insulin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Insulin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Insulin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Insulin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Insulin include Novo Nordisk, Eli Lilly, Sanofi-Aventis, Tonghua Dongbao, Ganlee, United Laboratory and Jiangsu Wanbang, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Insulin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Insulin, also provides the sales of main regions and countries. Of the upcoming market potential for Insulin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Insulin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Insulin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Insulin sales, projected growth trends, production technology, application and end-user industry.

Insulin segment by Company

Novo Nordisk
Eli Lilly
Sanofi-Aventis
Tonghua Dongbao
Ganlee
United Laboratory
Jiangsu Wanbang
Insulin segment by Type

Animal Insulin
Regular Human Insulin
Insulin Analogue
Insulin segment by Application

Short Acting
Intermediate Acting
Long Acting
Pre-Mix Insulin
Insulin segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia

Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Insulin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Insulin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Insulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Insulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Insulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report


1 Market Overview
1.1 Product Definition
1.2 Global Insulin Market Size, 2019 VS 2023 VS 2030
1.3 Global Insulin Market Size Estimates and Forecasts (2019-2030)
1.4 Global Insulin Sales Estimates and Forecasts (2019-2030)
1.5 Global Insulin Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Insulin Market Dynamics
2.1 Insulin Industry Trends
2.2 Insulin Industry Drivers
2.3 Insulin Industry Opportunities and Challenges
2.4 Insulin Industry Restraints
3 Insulin Market by Manufacturers
3.1 Global Insulin Revenue by Manufacturers (2019-2024)
3.2 Global Insulin Sales by Manufacturers (2019-2024)
3.3 Global Insulin Average Sales Price by Manufacturers (2019-2024)
3.4 Global Insulin Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Insulin Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Insulin Manufacturers, Product Type & Application
3.7 Global Insulin Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Insulin Market CR5 and HHI
3.8.2 Global Top 5 and 10 Insulin Players Market Share by Revenue in 2023
3.8.3 2023 Insulin Tier 1, Tier 2, and Tier 3
4 Insulin Market by Type
4.1 Insulin Type Introduction
4.1.1 Animal Insulin
4.1.2 Regular Human Insulin
4.1.3 Insulin Analogue
4.2 Global Insulin Sales by Type
4.2.1 Global Insulin Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Insulin Sales by Type (2019-2030)
4.2.3 Global Insulin Sales Market Share by Type (2019-2030)
4.3 Global Insulin Revenue by Type
4.3.1 Global Insulin Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Insulin Revenue by Type (2019-2030)
4.3.3 Global Insulin Revenue Market Share by Type (2019-2030)
5 Insulin Market by Application
5.1 Insulin Application Introduction
5.1.1 Short Acting
5.1.2 Intermediate Acting
5.1.3 Long Acting
5.1.4 Pre-Mix Insulin
5.2 Global Insulin Sales by Application
5.2.1 Global Insulin Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Insulin Sales by Application (2019-2030)
5.2.3 Global Insulin Sales Market Share by Application (2019-2030)
5.3 Global Insulin Revenue by Application
5.3.1 Global Insulin Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Insulin Revenue by Application (2019-2030)
5.3.3 Global Insulin Revenue Market Share by Application (2019-2030)
6 Global Insulin Sales by Region
6.1 Global Insulin Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Insulin Sales by Region (2019-2030)
6.2.1 Global Insulin Sales by Region (2019-2024)
6.2.2 Global Insulin Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Insulin Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Insulin Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Insulin Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Insulin Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Insulin Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Insulin Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Insulin Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Insulin Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 Global Insulin Revenue by Region
7.1 Global Insulin Revenue by Region
7.1.1 Global Insulin Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Insulin Revenue by Region (2019-2024)
7.1.3 Global Insulin Revenue by Region (2025-2030)
7.1.4 Global Insulin Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Insulin Revenue (2019-2030)
7.2.2 North America Insulin Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Insulin Revenue (2019-2030)
7.3.2 Europe Insulin Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Insulin Revenue (2019-2030)
7.4.2 Asia-Pacific Insulin Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Insulin Revenue (2019-2030)
7.5.2 LAMEA Insulin Revenue Share by Country: 2019 VS 2023 VS 2030
8 Company Profiles
8.1 Novo Nordisk
8.1.1 Novo Nordisk Comapny Information
8.1.2 Novo Nordisk Business Overview
8.1.3 Novo Nordisk Insulin Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Novo Nordisk Insulin Product Portfolio
8.1.5 Novo Nordisk Recent Developments
8.2 Eli Lilly
8.2.1 Eli Lilly Comapny Information
8.2.2 Eli Lilly Business Overview
8.2.3 Eli Lilly Insulin Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Eli Lilly Insulin Product Portfolio
8.2.5 Eli Lilly Recent Developments
8.3 Sanofi-Aventis
8.3.1 Sanofi-Aventis Comapny Information
8.3.2 Sanofi-Aventis Business Overview
8.3.3 Sanofi-Aventis Insulin Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Sanofi-Aventis Insulin Product Portfolio
8.3.5 Sanofi-Aventis Recent Developments
8.4 Tonghua Dongbao
8.4.1 Tonghua Dongbao Comapny Information
8.4.2 Tonghua Dongbao Business Overview
8.4.3 Tonghua Dongbao Insulin Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Tonghua Dongbao Insulin Product Portfolio
8.4.5 Tonghua Dongbao Recent Developments
8.5 Ganlee
8.5.1 Ganlee Comapny Information
8.5.2 Ganlee Business Overview
8.5.3 Ganlee Insulin Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Ganlee Insulin Product Portfolio
8.5.5 Ganlee Recent Developments
8.6 United Laboratory
8.6.1 United Laboratory Comapny Information
8.6.2 United Laboratory Business Overview
8.6.3 United Laboratory Insulin Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 United Laboratory Insulin Product Portfolio
8.6.5 United Laboratory Recent Developments
8.7 Jiangsu Wanbang
8.7.1 Jiangsu Wanbang Comapny Information
8.7.2 Jiangsu Wanbang Business Overview
8.7.3 Jiangsu Wanbang Insulin Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Jiangsu Wanbang Insulin Product Portfolio
8.7.5 Jiangsu Wanbang Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Insulin Value Chain Analysis
9.1.1 Insulin Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Insulin Production Mode & Process
9.2 Insulin Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Insulin Distributors
9.2.3 Insulin Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings